CRISPR Therapeutics AG Analysis
| Analyst Ratings |
|
Average Target Price
|
96.61
|
|
Average Rating
|
3.85
|
|
# Strong Buys
|
11
|
|
# Buys
|
4
|
|
# Holds
|
10
|
|
# Sells
|
1
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-2.37
|
0.00
|
2.37
|
100.00%
|
|
2022-12-31
|
-2.30
|
0.00
|
2.30
|
100.00%
|
|
2022-09-30
|
-2.29
|
-2.24
|
0.05
|
2.18%
|
|
2022-06-30
|
-2.23
|
-2.40
|
-0.17
|
-7.62%
|
|
2022-03-31
|
-1.94
|
-2.32
|
-0.38
|
-19.59%
|
|
2021-12-31
|
-1.77
|
-1.84
|
-0.07
|
-3.95%
|
|
2021-09-30
|
-1.76
|
-1.67
|
0.09
|
5.11%
|
|
2021-06-30
|
3.52
|
9.44
|
5.92
|
168.18%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-6.96
|
|
2021-12-31
|
4.42
|
|
2020-12-31
|
-5.27
|
|
2019-12-31
|
0.97
|
|
2018-12-31
|
-3.43
|
|
2017-12-31
|
-1.72
|
|
2016-12-31
|
-1.35
|